However, the core pathological mechanisms primarily involve pancreatic β-cell dysfunction and insulin resistance (IR) [4], driving therapeutic strategies focused on enhancing insulin secretion and improving insulin sensitivity. The gene discussed is INS; the disease is Insulin resistance.